The Effectiveness and Safety of Stellate Ganglion Block in the Treatment of Symptoms from Long COVID-19: A Pilot Study
Psychopharmacology Bulletin · 2025
DOI: 10.64719/pb.4500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychopharmacology Bulletin, 2025. Verfasst von Alexa O Levey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Levey, MD, Radiology Partners-Houston, Houston, TX, USA. Hauptthemen laut MEDLINE: Stellate Ganglion, Autonomic Nerve Block, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Purpose
Pilot study to evaluate the safety and effectiveness of stellate ganglion blocks in the treatment of symptoms related to long COVID infection. Materials and Methods A total of 17 patients who underwent stellate ganglion block for the treatment of their long COVID symptoms were included. COMPASS-31, GAD-7, PCL-5, and Fatigue Severity Score (FSS) pre and post intervention surveys and data on baseline heartrate and post- block heart rate recorded in the EMR.
Results
A total of 94% of patients reported moderate-to-severe autonomic dysfunction pre-procedure as measured by COMPASS-31. All patients reported some degree of symptomatic improvement from the block. Specifically, patients had significantly lower FSS scores ( P = 0.002) and heart rate post-procedure ( P = 0.008). Although the decrease in PCL-5 scores after the procedure was clinically meaningful, this change was not statistically significant ( P = 0.159). No significant difference was found in pre and post procedure GAD-7 scores ( P = 0.101).
Conclusions
Stellate ganglion block is a safe, low-risk, minimally invasive, and effective procedure in the treatment of symptoms for long COVID. It should be evaluated as an adjunctive treatment of select patients in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Levey, MD, Radiology Partners-Houston, Houston, TX, USA.
- Chen, MD, MBA, University of Texas Health Sciences Center at Houston, McGovern Medical School, Department of Anesthesiology, Critical Care, and Pain Medicine, Houston, TX, USA.
- Ngyuen, MD, University of Texas Health Sciences Center at Houston, McGovern Medical School, Department of Anesthesiology, Critical Care, and Pain Medicine, Houston, TX, USA.
- Ostrosky-Zeichner, MD, University of Texas Health Sciences Center at Houston, McGovern Medical School, Department of Internal Medicine, Division of Infectious Diseases, Houston, TX, USA.
- Hasoon, MD, University of Texas Health Sciences Center at Houston, McGovern Medical School, Department of Anesthesiology, Critical Care, and Pain Medicine, Houston, TX, USA.
- Saroukhani, MD, PhD, University of Texas Health Sciences Center at Houston, McGovern Medical School, Department of Internal Medicine, Division of Clinical and Translational Sciences, Houston, TX, USA.
Förderung
- NCATS NIH HHS
Zitieren
APA
Levey, A. O., Chen, G. H., Ngyuen, A., Ostrosky-Zeichner, L., Hasoon, J., Saroukhani, S., & Lin, M. (2025). The Effectiveness and Safety of Stellate Ganglion Block in the Treatment of Symptoms from Long COVID-19: A Pilot Study. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.4500
Vancouver
Levey AO, Chen GH, Ngyuen A, Ostrosky-Zeichner L, Hasoon J, Saroukhani S, et al. The Effectiveness and Safety of Stellate Ganglion Block in the Treatment of Symptoms from Long COVID-19: A Pilot Study. Psychopharmacology Bulletin. 2025. doi:10.64719/pb.4500
BibTeX
@article{Levey2025,
author = {Levey, Alexa O and Chen, Grant H and Ngyuen, Alexandra and Ostrosky-Zeichner, Luis and Hasoon, Jamal and Saroukhani, Sepideh and Lin, Matthew},
title = {The Effectiveness and Safety of Stellate Ganglion Block in the Treatment of Symptoms from Long COVID-19: A Pilot Study},
journal = {Psychopharmacology Bulletin},
year = {2025},
doi = {10.64719/pb.4500}
}
EUVIMED